Bailard’s Esperion Therapeutics ESPR Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,000	Closed	-$212K	–	727
2021 Q2	$212K	Sell	10,000 -13,000	-57%	-$276K	0.01%	660
2021 Q1	$645K	Hold	23,000	–	–	0.02%	333
2020 Q4	$598K	Sell	23,000 -75,500	-77%	-$1.96M	0.03%	288
2020 Q3	$3.66M	Hold	98,500	–	–	0.19%	98
2020 Q2	$5.05M	Buy	98,500 +5,200	+6%	+$267K	0.28%	77
2020 Q1	$2.94M	Buy	93,300 +3,400	+4%	+$107K	0.21%	95
2019 Q4	$5.36M	Sell	89,900 -1,000	-1%	-$59.6K	0.3%	78
2019 Q3	$3.33M	Buy	90,900 +14,700	+19%	+$539K	0.2%	106
2019 Q2	$3.55M	Buy	76,200 +16,700	+28%	+$777K	0.22%	99
2019 Q1	$2.39M	Buy	59,500 +50,500	+561%	+$2.03M	0.15%	140
2018 Q4	$414K	Hold	9,000	–	–	0.03%	340
2018 Q3	$399K	Hold	9,000	–	–	0.02%	423
2018 Q2	$353K	Sell	9,000 -50,300	-85%	-$1.97M	0.02%	428
2018 Q1	$4.29M	Sell	59,300 -16,000	-21%	-$1.16M	0.27%	91
2017 Q4	$4.96M	Buy	75,300 +12,000	+19%	+$790K	0.31%	71
2017 Q3	$3.17M	Hold	63,300	–	–	0.25%	103
2017 Q2	$2.93M	Buy	63,300 +22,300	+54%	+$1.03M	0.24%	103
2017 Q1	$1.45M	Buy	+41,000	New	+$1.45M	0.12%	149
2016 Q1	–	Sell	-9,000	Closed	-$200K	–	283
2015 Q4	$200K	Buy	+9,000	New	+$200K	0.09%	191